user image
Michelle R BoroskI
Physician Assistant

Prescriptions made by Michelle R BoroskI

Data for 2018

366

Medicare Part D Prescriptions Filled, Including Refills

Rank: 1,477 out of 5,636 providers in this state and specialty

$8,388

Total Retail Price of All Prescriptions

Rank: 2,971 out of 5,636 providers in this state and specialty

188

Patients Receiving at Least One Drug in Part D

Rank: 448 out of 5,636 providers in this state and specialty

-

Average Risk Score

Not enough data available

71

Average Age of Patients

Average age of patients for providers in this state and specialty is 69

Drug Categories

O

Opioid

An opioid drug. Prescription opioids (painkillers) can help alleviate certain kinds of pain in the short term but carry serious health risks.
A

Antibiotic

Used to treat bacterial infections but are often prescribed incorrectly to treat viral infections, such as chest colds or the flu.
P

Antipsychotic

Used to manage psychosis, principally in schizophrenia but also in a range of other psychotic disorders.

Prescription Data

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume. Rank in State ranks all providers that have the self-identified specialty of Physician Assistant in Texas and ranks the number of prescriptions that have been made for the specific drug.

Drug Name Rank in State Total Prescriptions Filled with Refills Prescript. to 65+ Patients Receiving this Drug Patients 65+ OAP
1 ONDANSETRON ODT
(ONDANSETRON)
20
of 3000
1330 prescriptions
Less than 1% of all prescriptions
1330 patients
71% of all patients
< 11
2 GAVILYTE-C
(PEG3350/SOD SULF,BICARB,CL/KCL)
10
of 20
1000 prescriptions
Less than 1% of all prescriptions
990 patients
53% of all patients
< 11
3 PEG 3350-ELECTROLYTE
(PEG3350/SOD SULF,BICARB,CL/KCL)
10
of 40
700 prescriptions
Less than 1% of all prescriptions
700 patients
37% of all patients
< 11
4 ONDANSETRON HCL140
of 2590
420 prescriptions
Less than 1% of all prescriptions
420 patients
22% of all patients
< 11